A Phase 1, Multi-Center, Open-Label, dose Escalation Study of Thrombosomes in Bleeding thrombocytopenic Patients in Three Cohorts
This study evaluates in a dose-escalation manner, the safety, and preliminary impact on bleeding, and the preliminary effect on coagulation measures of increasing doses of allogeneic Thrombosomes in thrombocytopenic patients.
Available at the following location(s)
Do you need help with some of the labels on this page?
Read our glossary of terms